Michael Roberts – Chief Scientific Officer
Dr Michael Roberts read Biochemistry at the University of Glasgow, where he took a first class bachelor of sciences honors degree. He subsequently studied for his doctorate at the University of Cambridge where his interest in the elements controlling gene expression was stimulated. After post-doctoral work at Royal Holloway, University of London, in one of the leading gene therapy groups in Europe and a two-year Marie Curie fellowship in the National Hellenic Research Foundation in Greece, Dr Roberts was appointed head of Research and Development at Regulon Inc. Whilst at Regulon he developed the company’s molecular biology research facility and was ultimately appointed to the board of directors. Dr Roberts went on to found Synpromics in 2010 to develop synthetic promoters for commercial applications.